A group of compounding pharmacies has filed a lawsuit against the FDA, challenging the agency’s decision to remove semaglutide — which is used to treat Type 2 diabetes and obesity — from the drug shortage list.
AstraZeneca’s experimental breast cancer drug camizestrant, when combined with a cyclin-dependent kinase inhibitor, has shown significant improvement in delaying disease progression in patients with hormone receptor-positive, HER2-negative advanced bre…
Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas.
Meditech has launched a new web-based Expanse Outreach Portal, designed to help hospitals extend their laboratory services to nonaffiliated healthcare providers such as nursing homes, urgent care centers and physician offices.
King of Prussia, Pa.-based Universal Health Services posted a net income of $1.1 billion in 2024, up from a net income of $717.8 million in 2023, according to its Feb. 26 financial report.
Santa Clara, Calif.-based cardiology medtech company EBR Systems plans to relocate from its current headquarters in Sunnyvale, Calif., and move to an expanded space, according to a Feb. 26 report from East Bay Times.
At a time when many hospitals and health systems struggle to combat ongoing workforce challenges in the industry, San Diego-based Sharp HealthCare is cracking the code of strengthening recruitment and retention.
From advancements in diagnostic procedures to innovative business solutions, gastroenterology is a dynamic and evolving field with several key areas of future growth.